Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Anglo Asian Mining (AAZ) by Hot Stock Rockets in ShareProphets
- Sell Animalcare Group (ANCR) by Hot Stock Rockets in ShareProphets
- Avoid VP (VP.) by Steve Moore in ShareProphets
- Buy Kainos Group (KNOS) by Shore Capital
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Citi
- Buy Mondi (MNDI) by Citi
- Buy Barr (A.G.) (BAG) by Berenberg
- Buy Barratt Redrow (BTRW) by Citi
- Buy Computacenter (CCC) by Peel Hunt
- Neutral Melrose Industries (MRO) by Exane
- Underweight Hunting (HTG) by Barclays
- Outperform Linde (0M2B) by Bernstein
- Buy Tesco (TSCO) by UBS
- Buy easyJet (EZJ) by UBS
- Buy Barratt Redrow (BTRW) by Deutsche Bank
- Buy Plus500 Ltd (DI) (PLUS) by Jefferies
- Buy Tesco (TSCO) by Deutsche Bank
- Hold Sage Group (SGE) by Deutsche Bank
- Hold Workspace Group (WKP) by Deutsche Bank
- Buy M&C Saatchi (SAA) by Berenberg
Hikma Pharmaceuticals (HIK) Share Price
Health Care Sector
NOTE: This is based on 389 open tips for Hikma Pharmaceuticals (HIK)
| Latest Bid : 1,380.50p | Latest Ask : 1,381.50p |
| High Today : 1,387.50p | Low Today : 1,363.50p |
| This Years High : 2,148.00p | This Years Low : 1,191.00p |
| Volume : 170,575 | MKT Cap : £3044.28M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Hikma Pharmaceuticals (HIK) Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Hikma Pharmaceuticals (HIK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2025-11-07 16:31:00 07/11/2025 | -12.98% |
| Overweight | JP Morgan | Premium Only | 2025-11-07 16:16:00 07/11/2025 | -13.74% |
| Equal Weight | Barclays | Premium Only | 2025-11-07 06:39:00 07/11/2025 | 0.26% |
| Buy | Jefferies | Premium Only | 2025-11-07 04:44:00 07/11/2025 | -10.67% |
| Buy | Berenberg | Premium Only | 2025-11-06 18:00:00 06/11/2025 | -10.67% |
Hikma Pharmaceuticals (HIK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Kintbury Capital LLP | 2.21% | 15/04/2026 |
| AQR Capital Management, LLC | 0.5% | 12/05/2025 |
| Latest Bid : 1,380.50p | Latest Ask : 1,381.50p |
| High Today : 1,387.50p | Low Today : 1,363.50p |
| This Years High : 2,148.00p | This Years Low : 1,191.00p |
| Volume : 170,575 | MKT Cap : £3044.28M |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2025-11-07 16:31:00 07/11/2025 | -12.98% |
| Overweight | JP Morgan | Premium Only | 2025-11-07 16:16:00 07/11/2025 | -13.74% |
| Equal Weight | Barclays | Premium Only | 2025-11-07 06:39:00 07/11/2025 | 0.26% |
| Buy | Jefferies | Premium Only | 2025-11-07 04:44:00 07/11/2025 | -10.67% |
| Buy | Berenberg | Premium Only | 2025-11-06 18:00:00 06/11/2025 | -10.67% |